Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Saegis Pharmaceuticals logo — company profile

Saegis Pharmaceuticals

Founded 1999 Series B Total: $44.00M Biopharma, Biotechnology +1

General Information

Company Name Saegis Pharmaceuticals
Founded Year 1999
Industries Biopharma, Biotechnology, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Saegis Pharmaceuticals. To contact Saegis Pharmaceuticals, visit saegispharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Saegis Pharmaceuticals compare?

A PDF of Saegis Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Saegis Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Saegis Pharmaceuticals

Saegis Pharmaceuticals, established in 1999, is a biopharmaceutical company headquartered in Half Moon Bay, California. Specializing in the development of medications for behavioral disorders, the company boasts a robust pipeline targeting central nervous system diseases characterized by cognitive dysfunction. This includes conditions such as Alzheimer’s disease, mild cognitive impairment, ADHD, and cognitive impairment linked to schizophrenia. Saegis Pharmaceuticals' CNS therapeutics aim to address memory loss and cognitive deficits associated with aging, psychiatric disorders, and brain trauma. The company recently secured a significant $30.00M Series B investment on 17 November 2003, with participation from a notable group of investors including Polaris Partners, Sofinnova Partners, Technology Partners, Sofinnova Investments, Versant Ventures, and Neuro Ventures. With its focus on developing medications for conditions with substantial unmet medical needs, Saegis Pharmaceuticals is positioned to make a meaningful impact in the biopharmaceutical and healthcare industries.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $30.00M 6
Polaris Partners Sofinnova Partners Technology Partners
Polaris Partners, Sofinnova Partners +4
17 Nov 2003
Series A $14.00M 1
Sofinnova Investments
Sofinnova Investments
01 Jan 2001

Saegis Pharmaceuticals Alternatives & Competitors

Saegis Pharmaceuticals vs
AgeneBio
AgeneBio United States

AgeneBio, Inc., is an emerging pharmaceutical company dedicated to developing innovative therapeutic...

Grant
4 employees
Biotechnology, Health Care
Saegis Pharmaceuticals vs
Chase Pharmaceuticals
Chase Pharmaceuticals

Pioneering advancements in neuropsychiatric treatment for a brighter future

Series B
11-50 employees
Biotechnology, Health Care

FAQ About Saegis Pharmaceuticals

Saegis Pharmaceuticals focuses on developing medications for behavioral disorders. The company has a robust pipeline targeting central nervous system diseases that involve cognitive dysfunction such as Alzheimer’s disease, mild cognitive impairment, ADHD, and cognitive impairment linked to schizophr...
Saegis Pharmaceuticals was founded in 1999.
Saegis Pharmaceuticals operates in Biopharma, Biotechnology and Health Care.
Saegis Pharmaceuticals has completed 2 funding rounds, raising a total of $44.00M. The latest funding stage is Series B.
Top alternatives and competitors to Saegis Pharmaceuticals include AgeneBio, Chase Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Saegis Pharmaceuticals and AgeneBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Saegis Pharmaceuticals, https://bouncewatch.com/company/saegis-pharmaceuticals, updated 26 July 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout